Kisspeptin-10 vs TriMix
A side-by-side research comparison of Kisspeptin-10 and TriMix across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | Kisspeptin-10 | TriMix |
|---|---|---|
| Full name | Kisspeptin-10 (Metastin 45-54) | TriMix (Papaverine + Phentolamine + Alprostadil) |
| Category | Sexual Health | Sexual Health |
| Status | Research compound | Compounded medication |
| Mechanism | Binds KISS1R on GnRH neurons, stimulating GnRH pulsatile release for LH/FSH secretion. Also enhances limbic sexual arousal circuits. | Papaverine relaxes smooth muscle via PDE inhibition. Phentolamine blocks alpha-adrenergic receptors. Alprostadil (PGE1) directly stimulates cAMP production in cavernosal tissue. Together they produce reliable penile erection independent of arousal. |
| Molecular weight | 1,302 Da | Combination compound |
| Half-life | 4-6 min (IV) / 20-30 min (SubQ) | ~1-3 hours (local effect) |
| Bioavailability | High (IV/SubQ) | Direct intracavernosal: ~100% |
| Typical dose | 1-10 nmol/kg | 0.1-0.5 mL (titrated) |
| Frequency | Single dose or daily | As needed, max 3x/week |
| Route | IV or Subcutaneous | Intracavernosal injection |
Kisspeptin-10 reported benefits
- Stimulates GnRH naturally
- Increases LH and testosterone
- Enhances sexual arousal (fMRI data)
- Potential fertility aid
- HPG axis diagnostic tool
TriMix reported benefits
- Reliable erectile response
- Works when oral meds fail
- Rapid onset (5-15 min)
- Adjustable dosing
- No systemic cardiovascular effects
Related comparisons
Research and educational reference only. Not medical advice.